Aurobindo to widen US portfolio, enter new markets in Europe

Lower generics penetration in Italy, Spain, Portugal and France offers future growth potential in next three to four years as share of generics improves, it added.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news